Skip to content
MarketScale
‹ Back to IndustriesHealthcare

THE HEAT IS ON HEAT-RELATED ILLNESSES – BE AWARE OF THE BASICS, PROTECT LIVES

Prolonged or intense exposure to hot temperatures can cause heat-related illnesses. The target groups at risk do range from the elderly to children, from construction workers to athletes. The good news is that by reducing excessive sun exposure and by taking precautionary steps, such as drinking lots of water, taking rest breaks, wearing light, protective…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Prolonged or intense exposure to hot temperatures can cause heat-related illnesses. The target groups at risk do range from the elderly to children, from construction workers to athletes. The good news is that by reducing excessive sun exposure and by taking precautionary steps, such as drinking lots of water, taking rest breaks, wearing light, protective clothing, most heat-related illnesses can be prevented. The bad news is that if not managed promptly and properly, some heat-related illnesses can be deadly. So beware of the symptoms and remember to seek medical assistance when in doubt or symptoms persist:

  • Heat Stroke – With this illness, the body’s temperature rises, and the heartbeat quickens. Skin is hot and red. Other physical symptoms include dizziness, headache, and nausea. If these symptoms are present, contact emergency services right away. For immediate treatment, move the person to a more cooling space and attempt to decrease the body temperature. Also, resist giving the person any water or fluids.
  • Heat Exhaustion – This condition is characterized by heavy sweating, clammy skin and a weak pulse. The person typically becomes tired and may faint. Move the person to a cooler area and apply cold packs to the body. Seek emergency help if symptoms intensify.
  • Heat Cramps – The heat can cause muscles to cramp up and have spasms. When a person feels this type of muscle pain, they should rest until the pain subsides before resuming physical activity.
  • Sunburn – If the skin becomes blistered, this is much more than getting a little sun. It’s best to remove the person from direct sunlight. Individuals with sunburns should resist going back into the sun without proper protection.
  • Heat Rash – Heat causes rashes, too. Small patches of skin may look burnt or blistery. If this occurs, direct affected person to a cool place and keep the outbreak dry, so it does not spread further.

“Cool Zones” have proven invaluable for athletes and workers alike to rest and recover from high heat. Those covered areas often provide water and misting stations for refreshment.

Effective cooling solutions, perfect for open and partially covered spaces are also the Power Breezerand the O2. The heat is on and we at Breezer Mobile Cooling believe that everyone deserves to be cool. Learn more about how we do that by getting in touch.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512